Okładka

Targeting TLR9 agonists to secondary lymphoid organs induces potent immune responses against HBV infection

Despite the existence of a prophylactic vaccine against hepatitis B virus (HBV), chronic hepatitis B virus (CHB) infection remains the leading cause of cirrhosis and liver cancer in developing countries. Because HBV persistence is associated with insufficient host immune responses to the infection,...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Irina Ushach (Autor), Ren Zhu (Autor), Elen Rosler (Autor), Rajendra K. Pandey (Autor), N. Tilani S. De Costa (Autor), Soheil Pourshahian (Autor), Qinglin Han (Autor), Chris Li (Autor), Leonid Beigelman (Autor), Sergei M. Gryaznov (Autor), Theodore Yun (Autor)
Format:	Książka
Wydane:	Elsevier, 2022-03-01T00:00:00Z.
Hasła przedmiotowe:	article
Dostęp online:	Connect to this object online.
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

The Role Placental TLR-7 Expression with Cord Blood HBV DNA and Placental HBV DNA
od: Naeny Fajriah, i wsp.
Wydane: (2022)

Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
od: Hassan Javanbakht, i wsp.
Wydane: (2018)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
od: Hong Liang, i wsp.
Wydane: (2022)

Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV
od: A.B. Macedo, i wsp.
Wydane: (2017)

Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules
od: C. Cheng Kao, i wsp.
Wydane: (2022)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
od: Marina Luchner, i wsp.
Wydane: (2021)

Periodontal sources of citrullinated antigens and TLR agonists related to RA
od: Ljubomir Vitkov, i wsp.
Wydane: (2018)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
od: Deepender Kaushik, i wsp.
Wydane: (2020)

A potent peptide as adiponectin receptor 1 agonist to against fibrosis
od: Lingman Ma, i wsp.
Wydane: (2017)

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
od: Fei-lin Ge, i wsp.
Wydane: (2021)

Pam2CSK4 (TLR2 agonist) induces periodontal destruction in mice
od: João Antonio Chaves de SOUZA, i wsp.
Wydane: (2020)

Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
od: Aashna Jassal, i wsp.
Wydane: (2024)

Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report
od: Chien-Yu Chen, i wsp.
Wydane: (2022)

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
od: Ashana Puri, i wsp.
Wydane: (2019)

Morphological Features of Lymphoid Structures of Nasooropharynx in Children with Hyperplasia of Pharyngeal Lymphoid Ring
od: L.S. Ovcharenko, i wsp.
Wydane: (2015)

Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.
od: Lu Huang, i wsp.
Wydane: (2015)

Combination of TLR agonist and miR146a mimics attenuates ovalbumin-induced asthma
od: Xinhua Wang, i wsp.
Wydane: (2020)

PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling
od: Nasim Dana, i wsp.
Wydane: (2019)

Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists
od: Sameer Agarwal, i wsp.
Wydane: (2019)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
od: Si-Yu Yuan, i wsp.
Wydane: (2022)

Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes
od: Dandan Wan, i wsp.
Wydane: (2024)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers
od: Joseph F. Grippo, i wsp.
Wydane: (2021)

Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
od: Huihui Lu, i wsp.
Wydane: (2021)

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
od: Xiao-Zhen Kang, i wsp.
Wydane: (2018)

Novel TRPV1 Channel Agonists With Faster and More Potent Analgesic Properties Than Capsaicin
od: Yorley Duarte, i wsp.
Wydane: (2020)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
od: Richard C. Kevin, i wsp.
Wydane: (2019)

A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
od: Sae-Bom Yoon, i wsp.
Wydane: (2023)

Delay in viral rebound with TLR7 agonist, N6-LS and PGT121 in SHIV-infected macaques
od: D. Hsu, i wsp.
Wydane: (2019)

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
od: Nazi Song, i wsp.
Wydane: (2022)

Histopathological approach to cutaneous lymphoid infiltrate
od: Uma Nahar Saikia, i wsp.
Wydane: (2019)

Development of venetoclax for therapy of lymphoid malignancies
od: Zhu H, i wsp.
Wydane: (2017)

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
od: Cristina Stasi, i wsp.
Wydane: (2016)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
od: Ye Zheng, i wsp.
Wydane: (2022)

Ability of TLR agonists to upregulate Brucella abortus strain RB51 mediated protection in a murine respiratory model
od: M Walker, i wsp.
Wydane: (2019)

First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
od: Cesar Miranda-Verastegui, i wsp.
Wydane: (2009)

Oral TLR7 agonist administration induces an immunostimulatory response in SIV-infected ART-suppressed infant rhesus macaques
od: K. Bricker, i wsp.
Wydane: (2019)

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development
od: Neeltje Steeghs, i wsp.
Wydane: (2022)

Characterization of acute TLR-7 agonist-induced hemorrhagic myocarditis in mice by multiparametric quantitative cardiac magnetic resonance imaging
od: Nicoleta Baxan, i wsp.
Wydane: (2019)

Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
od: Aaron Prodeus, i wsp.
Wydane: (2014)

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
od: Lili Xi, i wsp.
Wydane: (2023)